Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
MDxHealth (R): Extraordinary General Shareholders’ Meeting | |||
By: Nasdaq / GlobeNewswire - 21 Jun 2019 | Back to overview list |
||
NEWS RELEASE REGULATED INFORMATION Extraordinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – 18:00 CET, June 21, 2019 – MDxHealth SA (Euronext: MDXH) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda items of the Extraordinary General Shareholders' Meeting. About MDxHealth MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of therapeutic response. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
Disclaimer NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AssureMDx, PredictMDx and UrNCollect are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners. Attachment |
|||
|
|||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |